Sophia Genetics SOPH
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$3.15M (6 inflow days, 14 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 31.5% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 1.09% to 1.35% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Royce & Associates, LP | Mutual Fund | 2026/Q3 | +506,007 | 4.5% |
| Sowell Financial Services, LLC | Mutual Fund | 2026/Q3 | +341,889 | 0.4% |
| Acadian Asset Management LLC | Mutual Fund | 2026/Q3 | +324,010 | 0.4% |
| Morgan Stanley | Public Company | 2026/Q3 | +276,285 | 0.4% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +276,285 | 0.4% |
| Ensign Peak Advisors Inc. | Endowment Fund | 2026/Q3 | +237,158 | 0.8% |
| Squarepoint OPS LLC | Hedge Fund | 2026/Q3 | +195,696 | 0.2% |
| LPL Financial LLC | Mutual Fund | 2026/Q3 | +168,498 | 0.2% |
| Renaissance Technologies Corp. | Hedge Fund | 2026/Q3 | +157,600 | 0.3% |
| Landscape Capital Management, LLC | Hedge Fund | 2026/Q3 | +122,887 | 0.1% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +98,521 | 0.1% |
| Barclays PLC | Public Company | 2026/Q3 | +51,263 | 0.1% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +46,200 | 0.1% |
| Aigh Capital Management, LLC | Hedge Fund | 2026/Q3 | +3,954,194 | 4.6% |
| Columbia Management Investment Advisers, LLC | Mutual Fund | 2026/Q3 | +2,216,752 | 2.6% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 9 Nov 2026 | Kathy Hibbs | Independent Non-Executive Director | Automatic Disposition | -6,250 | $7.76 | 71,018 |
| 9 Nov 2026 | Jurgi Camblong | Co-Founder & Executive Chairperson | Automatic Disposition | -8,500 | $7.76 | 3,378,650 |
| 8 Nov 2026 | Daan van Well | Executive VP and Chief Legal & Compliance Officer | Automatic Disposition | -1,411 | $7.44 | 331,305 |
| 5 Nov 2026 | Ross Muken | Chief Executive Officer | Open Market Acquisition | +20,000 | $6.86 | 680,391 |
| 5 Nov 2026 | George Cardoza | Chief Financial Officer | Open Market Acquisition | +20,000 | $7.06 | 326,726 |
| 12 Oct 2026 | Zhenyu Xu | Chief Scientific Officer | Automatic Disposition | -4,000 | $7.18 | 541,493 |
| 11 Oct 2026 | Jurgi Camblong | Co-Founder & Executive Chairperson | Automatic Disposition | -8,500 | $7.26 | 3,387,150 |
| 11 Oct 2026 | Philippe Menu | Former Executive VP, Chief Medical Officer & Chief Product Officer | Automatic Disposition | -5,000 | $7.26 | 195,993 |
| 4 Oct 2026 | Ross Muken | Chief Executive Officer | Automatic Disposition | -9,838 | $8.13 | 660,391 |
| 4 Oct 2026 | George Cardoza | Chief Financial Officer | Automatic Disposition | -1,592 | $8.10 | 306,726 |
| 4 Oct 2026 | George Cardoza | Chief Financial Officer | Intent to Sell (Form 144) | -1,592 | $8.07 | – |
| 4 Oct 2026 | Jurgi Camblong | Co-Founder & Executive Chairperson | Automatic Disposition | -40,172 | $8.13 | 3,395,650 |
| 4 Oct 2026 | Jurgi Camblong | Chief Executive Officer | Intent to Sell (Form 144) | -65,672 | $8.07 | – |
| 4 Oct 2026 | Zhenyu Xu | Chief Scientific Officer | Automatic Disposition | -7,394 | $8.12 | 545,493 |
| 4 Oct 2026 | Zhenyu Xu | Chief Scientific Officer | Intent to Sell (Form 144) | -19,394 | $8.07 | – |
| 4 Oct 2026 | Kevin Puylaert | SVP & Chief Sales Officer | Open Market Disposition | -216 | $8.06 | 147,732 |
| 4 Oct 2026 | Manuela Da Valente | Executive Vice President | Automatic Disposition | -4,240 | $8.13 | 117,582 |
| 4 Oct 2026 | Manuela Da Valente | Chief Human Resources Officer | Intent to Sell (Form 144) | -4,240 | $8.07 | – |
| 4 Oct 2026 | Daan van Well | Executive VP and Chief Legal & Compliance Officer | Automatic Disposition | -6,168 | $8.12 | 332,716 |
| 4 Oct 2026 | Philippe Menu | Former Executive VP, Chief Medical Officer & Chief Product Officer | Automatic Disposition | -7,394 | $8.13 | 200,993 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 1,148,103 | 1.3% | 2.6 |
| 15 Oct 2026 | 1,000,143 | 1.2% | 1.5 |
| 30 Sep 2026 | 1,120,801 | 1.3% | 1.7 |
| 15 Sep 2026 | 1,069,499 | 1.3% | 1.7 |
| 31 Aug 2026 | 1,103,130 | 1.3% | 1.9 |
| 14 Aug 2026 | 930,712 | 1.1% | 1.7 |
No comments yet — be the first to weigh in on SOPH.
Sign in to join the discussion.